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Abstract 
This theme issue provides a comprehensive collection of original research articles as well as re-
views on the creation of diverse types of theranostic upconversion nanoparticles, their funda-
mental interactions in biology, as well as their biophotonic applications in noninvasive diagnostics 
and therapy. 
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This issue (volume 3, number 5) is the second 
theme issue in the series of “Theranostic Upconver-
sion Nanoparticles”.  The articles in this theme issue 
encompass 2 original research articles and 3 review 
articles. Yang et al. reviewed recent investigations on 
using upconversion nanoparticles (UCNPs) for the 
detection of biomolecules (avidin, ATP, etc.), ions 
(cyanide, mercury, etc.), small gas molecules (oxygen, 
carbon dioxide, ammonia, etc.), as well as for in vitro 
temperature sensing [1]. Liu et al. summarized the 
latest progresses regarding the applications of up-
conversion nanoparticles for photodynamic therapy, 
near-infrared (NIR) laser triggered drug and gene 
delivery, as well as several other upconversion na-
noparticle-based cancer therapeutic approaches [2]. 
Zhang et al. reviewed recent design and fabrication of 
multifunctional upconversion-magnetic hybrid 
nanostructured materials as well as their use for en-
hanced bioimaging and controlled drug delivery [3]. 
He et al. utilized the evanescent wave (EW) for the 
excitation of upconverison nanoparticles, providing a 
scanning-free as well as high contrast and high spati-
otemporal resolution method of tracking single na-
noparticles [4]. Li et al. reported on the use of upcon-
version NaLuF4:Yb,Tm nanophosphors for real-time 
upconversion luminescence imaging under ambient 
light and high-resolution X-ray CT imaging [5]. In 
sum, this special issue presents the frontline 
theranostic applications of upconversion nanoparti-
cles, which in turn encourages new directions for 
combined diagnosis and therapy. 
 Despite recent exciting developments in 
theranostic upconversion nanoparticles, challenges 
remain for those in the field. In this regard, we asked 
the following two questions: What is the major hurdle 
in the development of upconversion nanoparticles for 
biomedical applications? What may be the next big 
thing in his area? In order to answer these questions, 
we surveyed some of the leading scientists in the field. 
In the previous issue (volume 3, number 4) of 
Theranostics, we have presented opinions of several 
leading scientists in this field. In the subsequent par-
agraph, we continue to present the consensus of other 
ten leading scientists in five countries from this sur-
vey. 
So, what is the major hurdle in the development of 
upconversion nanoparticles for biomedical applications?  
Prof. Xiaogang Liu from Singapore National 
University, Prof. Xueyuan Chen from Fujian Institute 
of Research on the Structure of Matter, Chinese 
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Academy of Sciences, Prof. Stefan Andersson-Engels 
from Lund University, Prof. Zhuang Liu from Soo-
chow University, Prof. Fan Zhang from Fudan Uni-
versity, Prof. Jun Lin from Changchun Institute of 
Applied Chemistry, Chinese Academy of Sciences, 
Prof. Sailing He from Zhejiang University & Royal 
Institute of Technology (Sweden), Prof. Hong Zhang 
from University of Amsterdam, Prof. Xuefeng Yu 
from Wuhan University and one scientist from Mo-
lecular Foundry, Lawrence Berkeley National Labor-
atory, all believe that the efficiency of upconversion 
nanoparticles should be further increased in order to 
increase the bioimaging quality or to improve the 
detection limits. Profs. Xiaogang Liu, Stefan Anders-
son-Engels, and Sailing He also believed that a better 
way of excitation is necessary to avoid heating effect 
and to have high quantum yield. Prof. Stefan An-
dersson-Engels, Prof. Xuefeng Yu and a scientist from 
the Molecular Foundry, Lawrence Berkeley National 
Laboratory (LBNL) who did not want his name to be 
disclosed, also believed that the low extinction of 
lanthanide ions strongly limits the development of 
upconversion nanoparticles, especially small UCNPs, 
for biomedical applications. Prof. Zhuang Liu and 
Prof Hong Zhang also had concerns about the poten-
tial long-term toxicity of UCNPs. In addition, Prof. 
Shukun Xu from Northeastern University believed 
that smaller sized upconversion nanoparticles, pref-
erably less than 20 nm, would be more relevant for in 
vivo applications.  
What would be the next big thing in this area?  
Profs. Xiaogang Liu, Stefan Andersson-Engels, 
Zhuang Liu, Fan Zhang, Sailing He, Hong Zhang and 
Xuefeng Yu believed that significantly increased 
brightness (without increasing their sizes) by either 
broad-band sensitizing lanthanides or a better excita-
tion way, will impart upconversion nanoparticles a 
bright future. Prof. Xueyuan Chen believed that in 
vitro detection of tumor biomarkers, particularly those 
for early cancer detection, with these lantha-
nide-doped inorganic nano-bioprobes will be the next 
big thing. The scientist from LBNL also believed that 
efficient non-lanthanide-based upconverters will also 
be a breakthrough. Prof. Shukun Xu, thought that the 
next big thing in this field may be the successful de-
livery of drug molecules using UCNPs as carriers 
with controllable monitoring by luminescence imag-
ing. Professor Zhuang Liu also agreed  that the use of 
upconversion nanoparticles for some unique 
bio-applications that cannot be achieved by tradition-
al fluorescent probes (e.g. QDs) can be highly signifi-
cant. Prof. Jun Lin believed that the next big thing is to 
render these particles non-toxic and safe for admin-
istration to human beings. Prof. Xuefeng Yu men-
tioned hybrid nanocomposites (e.g., plasmonic na-
noparticle-based nanocomposites) and other new host 
materials as the next generation UCNPs. Upconver-
sion nanoparticles are new rising stars in current bi-
omedical fields. Nevertheless, further studies are 
needed to generate sufficient data to better under-
stand the long-term toxicity and safety of the UCNPs 
before introducing their wide applicability in medi-
cine. 
By summarizing the original and review articles 
from this and the previous issue [6], as well as the 
opinions from the leading scientists in the area, we 
found numerous distinct opinions about the future 
directions of this emerging field. Clearly, great op-
portunities and challenges co-exist to advance the 
field of theranostic upconversion nanoparticles, with 
hope of eventual clinical translation for diagnosing 
and treating human diseases. 
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